中华顶尖财经--信息搜索

信息搜索

信息关键字：应

共有3983条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200]

·【机构调研记录】西部利得基金调研华铁应急、海泰新光等3只个股（附名单）2022-12-9 9:04:44

·深企“出海”抢单返程；多公司回应熊去氧胆酸相关情况…重要消息还有这些2022-12-9 9:04:24

·熊去氧胆酸概念持续活跃多家上市公司回应产销情况2022-12-9 6:48:50

·最后3分钟20%跌停！乌龙指还是有情况？最新回应2022-12-9 1:20:56

·200亿光伏大项目仅投出81万，重新选址会否再存变数？公司最新回应2022-12-9 1:08:28

·最后3分钟20%跌停！乌龙指还是有情况？公司最新回应来了2022-12-8 22:03:31

·A股布洛芬概念股掀涨停潮多家上市公司回应情况2022-12-8 21:42:45

·A股布洛芬概念股掀涨停潮多家上市公司回应情况2022-12-8 21:42:43

·私募大佬周应波发声：当前处于“L型”探底过程中！2022-12-8 21:30:12

·“金牌供应商”佳力奇先发优势奠定市场基础推动企业快速发展2022-12-8 20:48:43

·多地核酸、方舱终止采购相关上市公司紧急回应2022-12-8 20:43:51

·宁波建工控股子公司组成的联合体中标宁波市轨道交通7、8号线一期工程下应南车辆段TJSG01标段施工2022-12-8 20:28:03

·宁德时代向本田供应123GWh动力电池将装配多少辆电动车？2022-12-8 19:28:07

·千红制药：公司产品熊去氧胆酸片的适应症为胆固醇型胆结石等2022-12-8 17:43:39

·特瑞斯12月13日北交所上市：深耕天然气输配及应用装备行业参与多项重大输气工程2022-12-8 17:22:56

·同仁堂：拟取得京宜生物51%股权未来向公司供应白酒基酒等战略资源2022-12-8 16:36:33

·科拓生物回应尾盘竞价“20cm”跌停：具体原因不清楚可能是乌龙指公司生产经营正常2022-12-8 16:23:54

·关于当前防疫你应该知道的50条科学信息2022-12-8 15:04:29

·积极应对收官月，“稳增长”政策发力成最大看点2022-12-8 14:35:05

·新冠是否应回归乙类管理？张伯礼：条件日趋成熟适时有序调整2022-12-8 13:33:26

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200]